Activation of CMA by the metformin-TAK1-IKKα/β Hsc70 signaling pathway reduced the level of accumulated Aβ plaques in the brain of AD mice, indicating that CMA activation to degrade Aβ may be a potential therapeutic strategy for AD [128]. The gene discussed is CHUK; the disease is Alzheimer disease.